Multicentre open-label study of neurotransmitters and neuropeptides in schizophrenia: a multidisciplinary study of biological, pharmacokinetic, receptor occupancy and clinical relationships in patients suffering from schizophrenia treated with quetiapine (Seroquel).
Phase of Trial: Phase II
Latest Information Update: 08 Oct 2012
At a glance
- Drugs Quetiapine (Primary)
- Indications Schizophrenia
- Focus Biomarker; Pharmacodynamics; Pharmacogenomic
- 23 Jan 2010 New trial record